10081--8/30/2006--BARR_PHARMACEUTICALS_INC

related topics

{product, liability, claim}

{regulation, change, law}

{regulation, government, change}

{cost, contract, operation}

Competition from other manufacturers of generic drugs affecting our generic products Competition from other manufacturers of generic drugs affecting our proprietary products Impact of At Risk launches Government Regulation and Managed Care Trends Cost and Expense Control/Unusual Events Availability of product liability insurance Use of estimates and judgments in applying accounting policies Changes in Laws and Accounting Standards

Full 10-K form ▸

related documents

1000736--3/2/2006--CAREMARK_RX_INC

918112--8/31/2009--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/

918112--9/28/2010--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/

874710--9/26/2008--ALLIED_HEALTHCARE_PRODUCTS_INC

1030206--2/2/2010--VASCULAR_SOLUTIONS_INC

874716--2/27/2008--IDEXX_LABORATORIES_INC_/DE

874710--9/28/2006--ALLIED_HEALTHCARE_PRODUCTS_INC

811669--2/24/2006--UST_INC

882873--9/21/2009--UROLOGIX_INC

1030206--2/5/2008--VASCULAR_SOLUTIONS_INC

1030206--2/3/2009--VASCULAR_SOLUTIONS_INC

893160--2/16/2007--VENTANA_MEDICAL_SYSTEMS_INC

810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC

10456--2/19/2009--BAXTER_INTERNATIONAL_INC

10081--2/29/2008--BARR_PHARMACEUTICALS_INC

1050007--11/29/2007--NUTRACEUTICAL_INTERNATIONAL_CORP

10795--11/24/2010--BECTON_DICKINSON_&_CO

1091596--2/26/2007--CYTOMEDIX_INC

811669--2/23/2007--UST_INC

862668--9/29/2008--ESCALON_MEDICAL_CORP

1050007--11/30/2006--NUTRACEUTICAL_INTERNATIONAL_CORP

10456--2/26/2008--BAXTER_INTERNATIONAL_INC

882873--9/20/2007--UROLOGIX_INC

739944--3/15/2007--MEDTOX_SCIENTIFIC_INC

1006195--6/8/2009--MATRIXX_INITIATIVES_INC

739944--3/17/2006--MEDTOX_SCIENTIFIC_INC

739944--3/11/2008--MEDTOX_SCIENTIFIC_INC

862668--10/12/2010--ESCALON_MEDICAL_CORP

1347022--2/12/2009--VeriChip_CORP

1110783--10/26/2007--MONSANTO_CO_/NEW/